FCCM
UTHR icon

First City Capital Management’s United Therapeutics UTHR Stock Holding History

First City Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-200
Closed -$22.3K – 502
2016
Q1 		$22.3K Hold
200
– – 0.02% 377
2015
Q4 		$31.3K Hold
200
– – 0.02% 337
2015
Q3 		$26.2K Hold
200
– – 0.02% 351
2015
Q2 		$34.8K Buy
200
+150
+300% +$27K 0.02% 318
2015
Q1 		$8.62K Buy
+50
New +$7.62K 0.01% 443

Other funds holding UTHR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

First City Capital Management's UTHR Position: Q2 2016 in Review

First City Capital Management sold out of United Therapeutics (UTHR) in Q2 2016, closing a stake of 200 shares — an estimated $22.3K sold.

First City Capital Management first reported a position in UTHR in Q1 2015 and held it in 5 quarters. The position peaked at $34.8K in Q2 2015. 384 funds tracked by Wall St. Rank hold UTHR as of Q2 2016.

  • First City Capital Management reported no remaining United Therapeutics position as of Q2 2016 after selling out during the quarter.
  • First City Capital Management sold 200 United Therapeutics shares in Q2 2016, an estimated $22.3K.
  • First City Capital Management first reported a position in United Therapeutics in Q1 2015 and held it in 5 quarters.
  • First City Capital Management's United Therapeutics position peaked at $34.8K in Q2 2015.
  • 384 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2016.

Based on First City Capital Management's 13F filing for Q2 2016, filed 16 Aug 2016.